⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4493809 | 0.67 | — | — | |
| SCHEMBL209117 | 0.60 | — | — | |
| SCHEMBL18663893 | 0.58 | — | — | |
| SCHEMBL10760430 | 0.58 | — | — | |
| SCHEMBL17602988 | 0.57 | — | — | |
| SCHEMBL8438270 | 0.57 | — | — | |
| SCHEMBL21500439 | 0.50 | — | — | |
| Naphthalene SCHEMBL1272176 | 0.43 | IDO1 (0.31) | — | |
| SCHEMBL10993767 | 0.43 | — | — | |
| SCHEMBL300801 | 0.43 | IDO1 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2002066041-A1 | NATURAL COMPOSITION | HERBAL DETOX THERAPY APS (DK) | 2002-08-29 | — | — | WO | claimed |
| US-9220692-B2 | Methods of reducing symptoms in subjects using single dosage forms with tapering release rates | TEVA WOMEN'S HEALTH, INC. (US) | 2015-12-29 | — | — | US | disclosed |
| EP-2133336-B1 | MODIFIED METAL COMPLEXES AND USE THEREOF | SUMITOMO CHEMICAL CO (JP) | 2014-05-07 | — | — | EP | disclosed |
| US-8519131-B2 | Modified metal complex and use thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-08-27 | — | — | US | disclosed |
| EP-2566877-A1 | METHODS OF REDUCING SYMPTOMS IN SUBJECTS USING SINGLE DOSAGE FORMS WITH TAPERING RELEASE RATES | Teva Women's Health, Inc. (US) | 2013-03-13 | — | — | EP | disclosed |
| WO-2011140375-A1 | METHODS OF REDUCING SYMPTOMS IN SUBJECTS USING SINGLE DOSAGE FORMS WITH TAPERING RELEASE RATES | DILIBERTI CHARLES E (US) | 2011-11-10 | — | — | WO | disclosed |
| US-20110274740-A1 | METHODS OF REDUCING SYMPTOMS IN SUBJECTS USING SINGLE DOSAGE FORMS WITH TAPERING RELEASE RATES | TEVA WOMEN'S HEALTH, INC. | 2011-11-10 | — | — | US | disclosed |
| US-20100129698-A1 | ELECTRODE CATALYST FOR FUEL CELL | NATIONAL INSTITUTE OF ADVANCED SCIENCE AND TECHNOLOGY (JP) | 2010-05-27 | — | — | US | disclosed |
| US-20100105909-A1 | MODIFIED METAL COMPLEX AND USE THEREOF | SUMITTO CHEMICAL COMPANY, LIMITED (JP) | 2010-04-29 | — | — | US | disclosed |
| US-7681572-B2 | Method and devices for administration of therapeutic gases | AGA AB (SE) | 2010-03-23 | — | — | US | disclosed |
| US-20050028816-A1 | Methods for easing pain and anxiety from atrial or ventricular defibrillation | AGA LINDE HEALTHCARE (SE) | 2005-02-10 | — | — | US | disclosed |
| US-20040129270-A1 | Method and devices for administration of therapeutic gases | AGA LINDE HEALTHCARE (SE) | 2004-07-08 | — | — | US | disclosed |
| WO-2004017889-A2 | METHODS AND DEVICES FOR ADMINISTRATION OF THERAPEUTIC GASES | AGA AB (SE) | 2004-03-04 | — | — | WO | disclosed |
| WO-2004018011-A2 | METHODS FOR EASING PAIN AND ANXIETY FROM ATRIAL OR VENTRICULAR DEFIBRILLATION | AGA AB (SE) | 2004-03-04 | — | — | WO | disclosed |
| WO-2002066041-A1 | NATURAL COMPOSITION | HERBAL DETOX THERAPY APS (DK) | 2002-08-29 | — | — | WO | disclosed |
| EP-0730453-A4 | METHODS OF TREATING CARDIAC ARRHYTHMIA | MERCK & CO INC (US) | 1998-03-04 | — | — | EP | disclosed |
| US-5597818-A | CARDIOVASCULAR DISORDERS | MERCK & CO., INC. (US) | 1997-01-28 | — | — | US | disclosed |
| EP-0730453-A1 | METHODS OF TREATING CARDIAC ARRHYTHMIA | MERCK & CO. INC. (US) | 1996-09-11 | — | — | EP | disclosed |
| US-5428031-A | Benzodiazepine analogs; cardiovascular disorders | MERCK & CO., INC. (US) | 1995-06-27 | — | — | US | disclosed |
| WO-1995014470-A1 | METHODS OF TREATING CARDIAC ARRHYTHMIA | MERCK & CO., INC. (US) | 1995-06-01 | — | — | WO | disclosed |